Schedule 13D ownership disclosure

ASTRIA THERAPEUTICS INC

Security class unavailable · CUSIP: 04635X102

Event date: 2022-12-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-310091
Form type
SC 13D/A
Filer
Astria Therapeutics, Inc.
CIK
CIK 1454789
Filed
Dec 21, 2022
Reporting period
Dec 19, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub